Sami Inkinen

Obviously, there's a distribution. Some are hugely successful in terms of moderately successful, but that message hasn't broken through yet. And it has to. And that's why I'm grateful to be on this podcast too, because it's ridiculous. There's no other way out of this metabolic health mess. GLP once in tap water is not going to solve this mess. No.

Yeah, absolutely. And first, upfront, I want to say that this may sound like, oh, this guy is so anti-pharmaceutical. No, I'm a physicist by training. I believe in science. I believe in Western medicine. And also these GLP-1 drugs, You know, first one was, I think in America approved for treating type two diabetes 2005. And it's a tool in a toolkit.

Yeah, absolutely. And first, upfront, I want to say that this may sound like, oh, this guy is so anti-pharmaceutical. No, I'm a physicist by training. I believe in science. I believe in Western medicine. And also these GLP-1 drugs, You know, first one was, I think in America approved for treating type two diabetes 2005. And it's a tool in a toolkit.

Yeah, absolutely. And first, upfront, I want to say that this may sound like, oh, this guy is so anti-pharmaceutical. No, I'm a physicist by training. I believe in science. I believe in Western medicine. And also these GLP-1 drugs, You know, first one was, I think in America approved for treating type two diabetes 2005. And it's a tool in a toolkit.

It is a tool in a toolkit for type two diabetes and in some cases for obesity. So I just want to be very clear. And obviously Virta, our providers practice evidence-based medicine. So anything I say next isn't going to be like, oh, you know, drugs are bad in all cases. No, that is not the case. But to answer your question, Specifically, and this is all data that's published in peer reviews.

It is a tool in a toolkit for type two diabetes and in some cases for obesity. So I just want to be very clear. And obviously Virta, our providers practice evidence-based medicine. So anything I say next isn't going to be like, oh, you know, drugs are bad in all cases. No, that is not the case. But to answer your question, Specifically, and this is all data that's published in peer reviews.

It is a tool in a toolkit for type two diabetes and in some cases for obesity. So I just want to be very clear. And obviously Virta, our providers practice evidence-based medicine. So anything I say next isn't going to be like, oh, you know, drugs are bad in all cases. No, that is not the case. But to answer your question, Specifically, and this is all data that's published in peer reviews.

So if anyone wants to sort of double check, you can go to VirtaHealth.com and slash research and find out published in peer review results. But indeed, so what we've been able to show is that as we run our nutrition program, among our patients, the following things either improve or get reversed. Obviously type two diabetes, so that's glycemic control. So blood sugar comes down.

So if anyone wants to sort of double check, you can go to VirtaHealth.com and slash research and find out published in peer review results. But indeed, so what we've been able to show is that as we run our nutrition program, among our patients, the following things either improve or get reversed. Obviously type two diabetes, so that's glycemic control. So blood sugar comes down.

So if anyone wants to sort of double check, you can go to VirtaHealth.com and slash research and find out published in peer review results. But indeed, so what we've been able to show is that as we run our nutrition program, among our patients, the following things either improve or get reversed. Obviously type two diabetes, so that's glycemic control. So blood sugar comes down.

Hypertension, so blood pressure comes down. Inflammation comes down. So this is CRP, C-reactive protein, a white blood cell count. And we also have an unpublished paper looking at 16 inflammation proteins of which almost all improve, which is unheard of, better than Humira. That's unpublished, so that's a caveat. Depressive symptoms improve. Sleep apnea improves, so it gets reversed.

Hypertension, so blood pressure comes down. Inflammation comes down. So this is CRP, C-reactive protein, a white blood cell count. And we also have an unpublished paper looking at 16 inflammation proteins of which almost all improve, which is unheard of, better than Humira. That's unpublished, so that's a caveat. Depressive symptoms improve. Sleep apnea improves, so it gets reversed.

Hypertension, so blood pressure comes down. Inflammation comes down. So this is CRP, C-reactive protein, a white blood cell count. And we also have an unpublished paper looking at 16 inflammation proteins of which almost all improve, which is unheard of, better than Humira. That's unpublished, so that's a caveat. Depressive symptoms improve. Sleep apnea improves, so it gets reversed.

Knee pain goes down. cardiovascular disease risk markers and 12-year cardiovascular risk goes down. Kidney and liver function improves. So we looked at EGFR and we can't really say that we can, it would be a little bit overreaching to say we reverse kidney disease, but we have shown that we improve kidney function and same with liver function. So when you look at these

Knee pain goes down. cardiovascular disease risk markers and 12-year cardiovascular risk goes down. Kidney and liver function improves. So we looked at EGFR and we can't really say that we can, it would be a little bit overreaching to say we reverse kidney disease, but we have shown that we improve kidney function and same with liver function. So when you look at these

Knee pain goes down. cardiovascular disease risk markers and 12-year cardiovascular risk goes down. Kidney and liver function improves. So we looked at EGFR and we can't really say that we can, it would be a little bit overreaching to say we reverse kidney disease, but we have shown that we improve kidney function and same with liver function. So when you look at these

broad spectrum metabolic health improvements. It's basically the same list that the GLP-1 manufacturers are now showing, that we either improve or reverse. And we've already published this data. So what can we conclude? Again, I'm not the medical doctor here, so maybe Krisma can kind of cover me up here a little bit. But basically what we can show is

broad spectrum metabolic health improvements. It's basically the same list that the GLP-1 manufacturers are now showing, that we either improve or reverse. And we've already published this data. So what can we conclude? Again, I'm not the medical doctor here, so maybe Krisma can kind of cover me up here a little bit. But basically what we can show is

broad spectrum metabolic health improvements. It's basically the same list that the GLP-1 manufacturers are now showing, that we either improve or reverse. And we've already published this data. So what can we conclude? Again, I'm not the medical doctor here, so maybe Krisma can kind of cover me up here a little bit. But basically what we can show is

It is possible to achieve the same broad metabolic health improvements as DLP once may or may not, nutritionally, 100% nutritionally. Therefore, It is not the exogenous molecule that is achieving these results alone, because it's possible to achieve the same results nutritionally. Now we can still debate the mechanism. Is it all about the weight loss or are there other things in play?